Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients

Schizophr Res. 2015 Oct;168(1-2):322-9. doi: 10.1016/j.schres.2015.07.013. Epub 2015 Aug 6.

Abstract

Background: Glutamatergic dysfunction and altered membrane lipid and energy metabolism have been repeatedly demonstrated in the frontal/prefrontal and anterior cingulate cortex (ACC) in schizophrenia. Though having been already studied in animals, the presumed link between glutamatergic function and structural plasticity has not been investigated directly in the human brain yet. We measured glutamate (Glu), focal energy metabolism, and membrane phospholipid turnover to investigate main pathologies in those key brain regions of schizophrenia.

Methods: (1)H- and (31)P-Chemical Shift Imaging (CSI) was combined in a single session to assess Glu and markers of energy (PCr, ATP) and membrane lipid (PME, PDE) metabolism in 31 neuroleptic-naïve first acute onset psychosis patients and 31 matched healthy controls. Multivariate analyses of covariance were used to assess disease effects on Glu and to investigate the impact of Glu alterations on phospholipid and energy metabolites.

Results: Glu levels of patients were increased in the frontal and prefrontal cortex bilaterally and in the ACC. Higher Glu was associated with increased left frontal/prefrontal PME and right frontal/prefrontal PDE in patients, which was not observed in healthy controls. In contrast, higher Glu levels were associated with lower PCr or ATP values in the frontal/prefrontal cortex bilaterally and in the right ACC of controls. This was not observed in the right ACC and left frontal/prefrontal cortex of patients.

Conclusion: Frontal glutamatergic hyperactivity is disconnected from physiologically regulated energy metabolism and is associated with increased membrane breakdown in right and increased membrane restoration in left frontal and prefrontal cortical regions. As indicated by previous findings, this pathology is likely dynamic during the course of first acute illness and possibly associated with negative symptoms and cognitive impairment. Our findings underline the importance of further research on neuroprotective treatment options during the early acute or even better for the ultra-high risk state of psychotic illness.

Keywords: (1)H-MRS; (31)P-MRS; CSI; Energy metabolism; First-episode psychosis; Glutamate; Phospholipids; Schizophrenia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analysis of Variance
  • Aspartic Acid / analogs & derivatives
  • Aspartic Acid / metabolism
  • Creatine / metabolism
  • Female
  • Glutamic Acid / metabolism*
  • Gyrus Cinguli / metabolism*
  • Humans
  • Lipid Metabolism*
  • Magnetic Resonance Imaging
  • Magnetic Resonance Spectroscopy
  • Male
  • Membrane Lipids / metabolism*
  • Phospholipids / metabolism
  • Phosphorus Isotopes / pharmacokinetics
  • Protons
  • Psychiatric Status Rating Scales
  • Schizophrenia / pathology*
  • Young Adult

Substances

  • Membrane Lipids
  • Phospholipids
  • Phosphorus Isotopes
  • Protons
  • Aspartic Acid
  • Glutamic Acid
  • N-acetylaspartate
  • Creatine